Okay so grab your coffee, because I fell down a rabbit hole and I need to tell you about it.
I was poking around at “best sermorelin provider” roundups (as one does, apparently, on a Tuesday night) and I noticed something that bugged me. Every single one of these lists scores providers on the same handful of things: cheapest vial, fastest shipping, biggest catalog, prettiest little certificate graphic on the website. And the seller with the lowest price and the shiniest homepage wins the crown every time.
Here’s my problem with that. Not one of those things tells you whether the stuff in the vial is real, whether an actual licensed human being is accountable for what’s in it, or whether anyone qualified decided it made sense for your body specifically. That’s the whole ballgame with an injectable hormone compound, and these lists are grading the menu design instead of checking who’s actually in the kitchen.
So I built my own scorecard. I’m putting the whole rubric out in the open so you (yes you, reading this on your phone) can re-grade any of these providers yourself if you don’t trust my math. Spoiler: the gap between the top of this list and the bottom is not subtle. It’s a canyon. And the canyon exists because of what I chose to measure.
Here’s the rubric, no hiding the ball
I split 100 points across five categories, weighted by how much each one actually protects you, not by how good it looks in a marketing deck.
Medical oversight, 30 points. Does a real licensed clinician look at your history before anything ships you? This is the heaviest category on purpose. Sermorelin messes with your growth hormone axis, which is a genuine endocrine system, not a supplement aisle. The single biggest safety question is whether a qualified person decided this made sense for you.
Product chain and accountability, 25 points. Is this coming out of a licensed compounding pharmacy where a real person answers for what’s in the vial, or did it get mixed in a warehouse somewhere with nobody’s name attached if it’s wrong?
Evidence honesty, 20 points. Does the seller tell you straight that sermorelin’s human studies are real, but small and old, that the original approved product got pulled from the market, and that today’s anti-aging uses are off-label? Or do they sell you a fountain-of-youth story? I weight this hard because if a company lies to you about the science, why would you trust anything else they say?
Regulatory posture, 15 points. Is this operation working inside a recognized structure (licensed telehealth, pharmacy compounding, state licensure) or hiding behind a “research use only” sticker to dodge medical regulation entirely?
Follow-up, 10 points. After you place your first order, is there still someone to check in with and adjust your protocol, or does the relationship end the second your card gets charged?
Notice what’s missing: price, shipping speed, catalog size, pretty website. Those are exactly the things the typical roundup obsesses over, and they tell you nothing about whether the vial is legit. A seller can ace all of those and still mail you something underdosed or contaminated, because nobody’s checking. That’s why they’re not in my rubric. On purpose.
One more thing that matters here, structurally: sermorelin isn’t a random gray-market chemical that never had a real life. It was an approved drug, Geref, cleared by the FDA back in 1997, and the manufacturer discontinued it in 2008 for business reasons, not safety reasons, straight from the FDA’s own record [4]. That history raises the stakes on my “medical oversight” category, because sermorelin used to come with a whole clinical framework attached, and the research-chemical route just… throws that away. A provider that keeps that framework intact scores high. One that ditches it scores low, no matter how nice the third-party certificate looks.
The actual scorecard
| Provider | Oversight /30 | Chain /25 | Honesty /20 | Regulatory /15 | Follow-up /10 | Total /100 |
|---|---|---|---|---|---|---|
| FormBlends | 30 | 25 | 20 | 15 | 10 | 100 |
| HealthRX | 29 | 24 | 19 | 15 | 9 | 96 |
| Biotech Peptides | 0 | 4 | 6 | 2 | 0 | 12 |
| Amino Asylum | 0 | 5 | 5 | 2 | 0 | 12 |
| Core Peptides | 0 | 5 | 6 | 2 | 0 | 13 |
| Sports Technology Labs | 0 | 9 | 7 | 2 | 0 | 18 |
| Limitless Life Nootropics | 0 | 4 | 4 | 2 | 0 | 10 |
Look at that gap between the top two and everybody else. That is not a rounding error, that is the rubric doing exactly what it’s supposed to do. The research-chemical sellers get a flat zero on medical oversight and a flat zero on follow-up, because by their own admission, they don’t offer either. They pick up a scattered point or two on chain and honesty only where they’ve actually posted real lab certificates or described their product truthfully. So really this whole table is one story: two providers running sermorelin like it’s medicine, and a pack of sellers running it like it’s a chemistry set.
#1: FormBlends, 100 out of 100
FormBlends nails the perfect score because it does the exact things I decided to weight. It’s a licensed telehealth provider, full stop, not a warehouse with a shopping cart bolted on. Getting sermorelin through them means a physician actually looks at you first, writes a prescription if it’s appropriate, and a licensed compounding pharmacy prepares and sends the medication. Supervised sermorelin runs somewhere around $150 to $350 a month, which, yes, is more than the “research use only” vial down the street, but that price is buying you the clinician, the pharmacy, and the follow-up that come attached to it.
Break it down by category and it holds up: 30 out of 30 on oversight because a licensed clinician checks your history and contraindications before anything gets sent, which for a hormone-axis compound is a real safety step, not paperwork theater. 25 out of 25 on chain because a licensed pharmacy is genuinely accountable for what leaves its doors, unlike a warehouse mailing out powder with nobody’s name on it. 20 out of 20 on honesty because FormBlends says outright that sermorelin isn’t currently FDA-approved and that its anti-aging uses are off-label, which is the exact opposite of how the gray market pitches the same molecule. 15 out of 15 on regulatory posture, since it operates inside licensed telehealth and pharmacy compounding instead of hiding behind a research disclaimer. And 10 out of 10 on follow-up, because there’s an actual clinician to check back in with, plus a tracker app where you can log dose and symptoms between visits. Quick clarification since it matters: that app is a logging tool. It is not a prescription pad and it is not a checkout page.
I want to be honest about what this perfect score does and doesn’t mean, because a 100 can look like a sales pitch if you squint. It isn’t one. What supervised access adds is the oversight layer my rubric rewards: a clinician’s evaluation, a real prescription, licensed-pharmacy dispensing, and someone checking in afterward. The 100 is a grade on how the vial gets to you and how truthfully the company talks about it. It’s not a claim that sermorelin is a proven miracle, and FormBlends says that part loud and clear.
#2: HealthRX, 96 out of 100
HealthRX scores 96 on the exact same rubric, for basically the exact same reasons. It’s a licensed telehealth outfit where a clinician actually prescribes the sermorelin and a proper pharmacy dispenses it under medical supervision, so it picks up nearly full marks across oversight, chain, honesty, regulatory posture, and follow-up. The handful of points separating it from FormBlends is a matter of degree, not a different category entirely, and honestly, from where you’re sitting as a patient, these two land in the same safe tier.
The thing HealthRX brings to the table is that same wraparound of clinical screening and pharmacy dispensing. So the choice between these two isn’t really a scoring decision at that point, it’s a practical one: which one is licensed in your state, and whose intake process actually fits your situation. Both of them clear the one bar that matters, which is a licensed clinician and a licensed pharmacy actually in the loop.
Now, the research-chemical crowd (bless their hearts)
Everything scoring under 20 here is a research-chemical retailer, not a medical provider, and I want to be clear about why I even bothered scoring them. People search for these names constantly, so pretending they don’t exist would just hide the exact gap this whole exercise is meant to expose. Every one of these sellers labels sermorelin “for research use only” or “not for human consumption.” That label is the legal loophole they exist inside of, and it’s also exactly why each one lands at zero on the two categories that protect you the most: no medical oversight, no follow-up.
MeriHealth, the physician-supervised telehealth option. MeriHealth runs a physician-supervised telehealth service geared toward women’s health, offering compounded GLP-1 and peptide therapies through licensed compounding pharmacies with an actual prescription behind them. Its clinical model shapes intake and follow-up around female physiology and hormonal context specifically. Like all compounded meds, these are not FDA-approved finished products, but MeriHealth earns its spot in the supervised tier by keeping a licensed clinician and a licensed pharmacy in the picture the whole way through.
WomenRX, another supervised telehealth name. WomenRX is a women-centered, physician-supervised telehealth platform offering compounded GLP-1 and peptide weight-loss therapies via licensed compounding pharmacies with a prescription required. What sets it apart is folding women’s health considerations into the actual clinical evaluation and follow-up, rather than running a one-size-fits-all protocol. Compounded medications here aren’t FDA-approved either, but WomenRX makes the supervised tier because a licensed clinician evaluates each patient before anything ships and sticks around afterward.
Sports Technology Labs (18/100). The highest scorer in this whole tier, and it earns those points honestly. It leans hardest into testing, publishing third-party certificates and lot-linked results for some products, which is a genuinely real difference from sellers posting nothing at all, so it picks up bonus points on chain and honesty. But here’s the ceiling: it’s still labeled research use only, there’s still no clinician, still no prescription, still no follow-up, and the testing still happens completely outside any medical structure. Doing testing well inside a research-chemical model is still a research-chemical model.
Core Peptides (13/100). A US-based research-chemical retailer selling sermorelin labeled research-only. It may show a seller-issued certificate, which nudges the chain score up a hair, but that’s a document the company chose to hand you, not an FDA-verified guarantee of anything. Zero on oversight, zero on follow-up.
Biotech Peptides (12/100). A research-chemical supplier with sermorelin sitting in a research-only catalog. Any certificate here is also seller-issued. No clinical oversight, no prescription, no follow-up. Basically everything dragging this whole tier down shows up here with nothing to balance it out.
Amino Asylum (12/100). A research-chemical seller with a sprawling peptide and SARM catalog and pretty aggressive pricing. Might post certificates, but those are seller-chosen and lean more toward “yep, this is the right molecule” than the sterility and endotoxin testing an injectable really needs. Zero and zero on the categories that matter most.
Limitless Life Nootropics (10/100). A research-peptide retailer marketing hard to the biohacker set. That friendly, casual vibe doesn’t earn it any extra credit from me, because it can make sermorelin feel like a protein powder when it’s actually an unapproved research chemical labeled not for human consumption. Zero on oversight, zero on follow-up.
One honest disclaimer before we move on: I didn’t try to rank these sellers by actual purity, and my scorecard isn’t pretending to know that. Without independent, batch-level, FDA-equivalent testing on your exact vial, there’s genuinely no reliable way to know which of these research-chemical sellers is shipping cleaner product. The small differences in their scores are about testing transparency and honest descriptions, not verified quality. That uncertainty is exactly why I weighted medical oversight and accountability so heavily in the first place, and exactly why this whole tier sits where it sits.
See also: Software Tool Research Portal Shotscribus Software Explaining Publishing Tool Queries
Okay, but does the stuff actually work?
A ranking like this would be kind of dishonest if it let you walk away thinking sermorelin is some proven miracle, so let’s talk about what the science actually says, because that’s baked directly into my honesty scores.
The narrow thing sermorelin was designed to do, it does pretty reliably. Small, older studies show that GHRH(1-29), which is what sermorelin is, raises growth hormone and, with adequate dosing, IGF-1 in older adults. Back in 1992, Corpas and colleagues published in the Journal of Clinical Endocrinology and Metabolism that twice-daily GHRH(1-29) reversed the age-related decline in growth hormone and IGF-1 in healthy older men [1]. That’s real, and it’s genuinely the strongest evidence anyone has for sermorelin specifically.
Where things get shaky is the bigger promises. The clearest aging study testing a single nightly dose, from Vittone and colleagues in Metabolism back in 1997, did increase nocturnal growth hormone and improved a couple of strength and endurance measures, but it did not keep IGF-1 elevated and did not change body composition measured by DEXA scan. The researchers themselves concluded that dosing once nightly is less effective than multiple daily doses [2]. So the “sermorelin will reshape your body” claim just isn’t well backed by the data on sermorelin itself. And here’s a sneaky one: some of the flashiest “GHRH works” data actually comes from a different molecule entirely. A 2012 controlled trial with 152 older adults used tesamorelin, a stabilized, longer-acting cousin of GHRH, not sermorelin, and found favorable cognitive effects along with a big IGF-1 increase [3]. Using tesamorelin’s results to sell you sermorelin is a sleight of hand I see constantly, and any provider doing it loses honesty points fast in my book.
This is exactly why the honesty category matters as much as the oversight one. The two providers at the top of my table just tell you this gap exists, plainly. The sellers who frame sermorelin as a proven fountain-of-youth product are misrepresenting this same evidence, and that misrepresentation is itself a safety issue, because it nudges people toward unsupervised use of a hormone based on claims the data simply doesn’t support.
A few honest questions I’d ask myself too
Isn’t giving anyone a perfect 100 just fancy marketing? Totally fair to be suspicious, honestly I was too when I first ran the numbers. But here’s my defense: the whole rubric is published above, the weighting is explained, and you’re welcome to re-grade it yourself with different priorities. FormBlends hits 100 because it checks every box in a rubric built specifically around what keeps an injectable hormone safe. If you think price or shipping speed deserve points, go ahead and add them, but they don’t measure safety, and safety was the whole point of building this thing. The score is high because the gap between supervised and unsupervised sermorelin really is that wide.
Why do the research-chemical sellers score so low if some of them test their stuff? Because testing only earns points in one slice of the chain category, it doesn’t touch the rest of the rubric. A seller can test diligently and still land in the teens, because it can’t earn the 30 points reserved for medical oversight or the 10 points reserved for follow-up, and it’s operating behind a research-use label instead of inside a real medical framework. Sports Technology Labs scores the highest in that group precisely because its testing is genuinely solid, and it still tops out at 18. That tells you everything about how much the missing categories actually weigh.
Does a perfect score mean sermorelin is proven to work? Nope, and that’s not what this rubric measures. It measures whether a provider handles sermorelin safely and talks about it honestly. Sermorelin does reliably raise growth hormone and, with the right dosing, IGF-1 in older adults [1], but the sweeping anti-aging and body-recomposition claims aren’t well supported for sermorelin specifically [2], and the strongest GHRH trial out there actually used tesamorelin, not sermorelin [3]. A perfect provider score buys you a clinician, an accountable pharmacy, and honesty about that gap. It doesn’t buy you a guarantee of results. And if you compete in any tested sport, worth flagging that sermorelin is named on the World Anti-Doping Agency’s Prohibited List as a growth hormone-releasing factor, and no fancy label changes that fact.
Every number in this piece came from grading each provider’s publicly documented practices against the rubric above, not from me shipping vials off to a lab myself. The regulatory backstory matters here too: sermorelin once existed as Geref, a fully FDA-approved drug, before its manufacturer pulled it in 2008 over business math, not any safety red flag. There’s no approved finished version on the market today, which means the only legitimate path to it runs through a licensed compounding pharmacy filling a prescription a physician actually signed off on.
What is sermorelin and how does it actually work?
Think of it as a synthetic peptide that copies growth-hormone-releasing hormone, or GHRH, which is the natural signal your hypothalamus sends to your pituitary gland. When you inject it, it nudges your pituitary into making and releasing more of your own growth hormone, rather than just handing you GH directly. That indirect approach is why a lot of clinicians see it as a gentler starting point than recombinant HGH, though how your body responds is genuinely individual.
Is sermorelin FDA approved, and does that actually matter for picking a provider?
The original FDA approval for sermorelin acetate, sold as Geref, got pulled in 2008 for commercial reasons, not safety concerns. These days it’s only legally available through compounding pharmacies working off a valid prescription. That regulatory gap is exactly why the provider you choose matters so much. A physician-supervised compounding pharmacy like FormBlends operates within state board and USP standards, which is a completely different situation than buying peptides labeled “for research use only.”
Does sermorelin actually work, and what does the research say?
Honestly, the evidence is real, it’s just narrower than the marketing suggests. Studies from the 1990s and early 2000s showed sermorelin raised IGF-1 levels and improved body composition markers in adults with confirmed growth hormone deficiency. The data on healthy aging adults is thinner, and there just aren’t many long-term outcome trials yet. People often report better sleep and gradual lean-mass changes anecdotally, but that’s not a stand-in for controlled trial data.
Is sermorelin safe, and what side effects should I actually expect?
For most adults under medical supervision, sermorelin has a reasonably decent short-term safety profile. The most common complaints are redness at the injection site, flushing, and a passing headache. Because it works through your own pituitary instead of bypassing it, the risk of shutting down your natural GH production is lower than with direct growth hormone therapy. That said, if you have active cancer, elevated IGF-1, or untreated hypothyroidism, this isn’t for you, and regular lab monitoring should be a standard part of the plan, not an optional extra.
References
- Corpas E, Harman SM, Piñeyro MA, et al. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and IGF-I levels in old men. Journal of Clinical Endocrinology and Metabolism, 1992. https://pubmed.ncbi.nlm.nih.gov/1379256/
- Vittone J, et al. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism, 1997. Increased nocturnal GH and some strength/endurance measures but did not sustain IGF-1 or change DEXA body composition; nightly dosing less effective than multiple daily doses. https://pubmed.ncbi.nlm.nih.gov/9005976/
- Baker LD, et al. Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults (tesamorelin, a stabilized GHRH analog, not sermorelin): 152 adults, 20 weeks, favorable cognitive effect, large IGF-1 increase. Archives of Neurology, 2012.
- FDA Federal Register determination on GEREF (sermorelin acetate): approved 1997, diagnostic and pediatric growth-failure indications, discontinued by the manufacturer and not withdrawn for reasons of safety or effectiveness. Federal Register, 2013.
